Fast-Acting Insulin Aspart Use with the MiniMedTM 670G System-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fast-Acting Insulin Aspart Use with the MiniMedTM 670G System

Published:2021-01-01 Issue:1 Volume:23 Page:1-7
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Hsu Liana¹²,Buckingham Bruce¹²,Basina Marina²³,Ekhlaspour Laya¹²,von Eyben Rie⁴,Wang Justin²,Lal Rayhan A.¹²³

Affiliation:

1. Division of Endocrinology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.

2. Stanford Diabetes Research Center, Stanford, California, USA.

3. Division of Endocrinology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.

4. Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California, USA.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2020.0083

Reference20 articles.

1. Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes

2. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials

3. Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes

4. Faster‐acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart

5. Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multicenter Evaluation of Ultra-Rapid Lispro Insulin with Control-IQ Technology in Adults, Adolescents, and Children with Type 1 Diabetes;Diabetes Technology & Therapeutics;2024-09-01

2. Postprandial Glucose Excursions with Ultra-Rapid Insulin Analogs in Hybrid Closed-Loop Therapy for Adults with Type 1 Diabetes;Diabetes Technology & Therapeutics;2024-07-01

3. Analogues ultra-rapides de l’insuline et délivrance automatisée de l’insuline, un réel pas en avant ?;Médecine des Maladies Métaboliques;2024-06

4. The Role of Ultra-Rapid-Acting Insulin Analogs in Diabetes: An Expert Consensus;Journal of Diabetes Science and Technology;2023-11-08

5. The artificial pancreas: two alternative approaches to achieve a fully closed-loop system with optimal glucose control;Journal of Endocrinological Investigation;2023-09-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3